GL1X · GenesisL1 explorer

MolNFT v1 · #104440 · protein

Structure of a dihydroxycoumarin active-site inhibitor in complex with the RNase H domain of HIV-1 reverse transcriptase

4QAG · Reverse TRANSCRIPTASE/RIBONUCLEASE H: “Structure of a dihydroxycoumarin active-site inhibitor in complex with the RNase H domain of HIV-1 reverse…”. X-ray diffraction, 2 ligands (F95, MN), 3 pockets (best druggability 0.47). MolNFT…

PDB
4QAG
Type
protein
Length
266 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Reverse TRANSCRIPTASE/RIBONUCLEASE H
EC
2.7.7.49, 2.7.7.7, 3.1.26.13, 3.1.13.2
UniProt
P03366
Ligands
F95, MN
Pockets
3 · best druggability 0.47

Structure

x-ray diffraction · 1 distinct chain · 35% helix, 25% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BReverse TRANSCRIPTASE/RIBONUCLEASE H (EC 2.7.7.49, 2.7.7.7, 3.1.26.13, 3.1.13.2)protein13335% helix, 25% strandP03366

Ligands and binding sites

  • F95 · (7,8-dihydroxy-2-oxo-2H-chromen-4-yl)acetic acid · ligand · 2 copies · chains A, B
  • MN · Manganese (II) ion · metal · 4 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12460.470.7336MN, F95
21190.390.7419empty
31250.380.7426empty

Interfaces

1 interface between chains.

  • A–B · 733 Ų buried · 16 hydrogen bonds · protein-protein

Compared structures

  • 4QAG · Structure of a dihydroxycoumarin active-site inhibitor in complex with the RNASE H domain… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.